Literature DB >> 2609725

Stability of recombinant vaccinia virus LC16m0 or LC16m8: preserved laboratory attenuation markers and conserved expression of inserted HBsAg gene.

K Watanabe1, M Morita, A Kojima.   

Abstract

Laboratory tests for the stability of attenuation markers of recombinant vaccinia viruses expressing HBsAg were carried out with those obtained after repeated passages in primary rabbit kidney cells. In these tests it was determined that recombinant vaccinia viruses preserved the attenuation markers of LC16m0 and LC16m8 strains used as vectors, with stable conservation of HBsAg gene expression. The stability of the recombinant vaccinia virus would add another strategy to the use of attenuated vaccinia virus for the development of recombinant vaccinia vaccine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2609725     DOI: 10.1016/0264-410x(89)90272-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.

Authors:  Minoru Kidokoro; Masato Tashiro; Hisatoshi Shida
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 2.  LC16m8: an attenuated smallpox vaccine.

Authors:  Julie Kenner; Fiona Cameron; Cyril Empig; David V Jobes; Marc Gurwith
Journal:  Vaccine       Date:  2006-04-21       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.